Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO's current and future strategy.

As the 'WHO Traditional Medicine Strategy: 2014-2023' is entering its final phase, reflection is warranted on progress and the focus for a new strategy. We used WHO documentation to analyse progress across the objectives of the current strategy, adding the role of traditional, complementary and integrative healthcare (TCIH) to address specific diseases as a dimension absent in the current strategy. Our analysis concludes on five areas. First, TCIH research is increasing but is not commensurate with TCIH use. TCIH research needs prioritisation and increased funding in national research policies and programmes. Second, WHO guidance for training and practice provides useful minimum standards but regulation of TCIH practitioners also need to reflect the different nature of formal and informal practices. Third, there has been progress in the regulation of herbal medicines but TCIH products of other origin still need addressing. A risk-based regulatory approach for the full-range of TCIH products seems appropriate and WHO should provide guidance in this regard. Fourth, the potential of TCIH to help address specific diseases is often overlooked. The development of disease strategies would benefit from considering the evidence and inclusion of TCIH practices, as appropriate. Fifth, inclusion of TCIH in national health policies differs between countries, with some integrating TCIH practices and others seeking to restrict them. We encourage a positive framework in all countries that enshrines the role of TCIH in the achievement of universal health coverage. Finally, we encourage seeking the input of stakeholders in the development of the new WHO Traditional Medicine Strategy.

Socio-culture and Health Problem Factors on Traditional Medicine Use among Indonesian Adult: A Cross-sectional Analysis from National Survey

Traditional medicines utilization has been significantly increased over the past years. Knowledge on traditional medicine use and its influencing socio-culture and health problem factors especially among generationally-related group in Indonesia is still limited. This study aimed to determine the prevalence and the association socio-culture and health problems factors and traditional medicine use among adults which were middle-aged (millennial) and elder-adult (generation X) in Indonesia while controlling other covariates. of traditional medicine use among This cross-sectional study used the data from the Indonesia Family Life Survey wave 5 (2014): a cross-sectional national population survey. This national survey used a multistage stratified random sampling to select the respondents to response to a structured questionnaire interview. There were 10,325 adults passed our inclusion criteria for the analysis. The adult who was born between1960 to 1982 was called the Gen X, whereas the Millennia is for those who were born between 1983 and 2000. A multivariable logistic regression was used to identify the association. Among 10,325 respondents, 78.42 % were millennial while 21.58 % were generation x or older adults.  Less than a quarter of the respondents used traditional medicine (13.37 %; 95% CI: 12.73-14.04). The factor significantly associated with traditional medicine used among Indonesian adults were; be Gen X (adj. OR = 1.24, 95%CI= 1.08 -1.43), female (adj.OR1.27, 95%CI: 1.13 to 1.43, p<0.001) Islamic (adj. OR = 1.91, 95%CI= 1.47 -2.36), married (adj. OR = 1.64, 95%CI= 1.44 -1.87),lived in urban area (adj. OR = 1.48, 95%CI= 1.31-1.68). Other covariate were unhealthy (adj.OR: 1.36, 95% CI: 1.18-1.1.58), experienced headache (adj.OR: 1.50, 95% CI: 1.31-1.47),  experienced stomachache (adj.OR: 1.28, 95% CI: 1.12-.47), and experienced fever (adj.OR: 1.30, 95% CI: 1.15- 1.47). Sociocultural and age group as well as health problems were associated with traditional medicine use.

A cross-sectional analysis of traditional medicine use for malaria alongside free antimalarial drugs treatment amongst adults in high-risk malaria endemic provinces of Indonesia.

BACKGROUND: The level of traditional medicine use, particularly Jamu use, in Indonesia is substantial. Indonesians do not always seek timely treatment for malaria and may seek self-medication via traditional medicine. This paper reports findings from the first focused analyses of traditional medicine use for malaria in Indonesia and the first such analyses worldwide to draw upon a large sample of respondents across high-risk malaria endemic areas. METHODS: A sub-study of the Indonesia Basic Health Research/Riskesdas Study 2010 focused on 12,226 adults aged 15 years and above residing in high-risk malaria-endemic provinces. Logistic regression was undertaken to determine the significant associations for traditional medicine use for malaria symptoms. FINDINGS: Approximately one in five respondents use traditional medicine for malaria symptoms and the vast majority experiencing multiple episodes of malaria use traditional medicine alongside free antimalarial drug treatments. Respondents consuming traditional medicine for general health/common illness purposes every day (odds ratio: 3.75, 95% Confidence Interval: 2.93 4.79), those without a hospital in local vicinity (odds ratio: 1.31, 95% Confidence Interval: 1.10 1.57), and those living in poorer quality housing, were more likely to use traditional medicine for malaria symptoms. CONCLUSION: A substantial percentage of those with malaria symptoms utilize traditional medicine for treating their malaria symptoms. In order to promote safe and effective malaria treatment, all providing malaria care in Indonesia need to enquire with their patients about possible traditional medicine use.

Utility of local health registers in measuring perinatal mortality: a case study in rural Indonesia.

BACKGROUND: Perinatal mortality is an important indicator of obstetric and newborn care services. Although the vast majority of global perinatal mortality is estimated to occur in developing countries, there is a critical paucity of reliable data at the local level to inform health policy, plan health care services, and monitor their impact. This paper explores the utility of information from village health registers to measure perinatal mortality at the sub district level in a rural area of Indonesia. METHODS: A retrospective pregnancy cohort for 2007 was constructed by triangulating data from antenatal care, birth, and newborn care registers in a sample of villages in three rural sub districts in Central Java, Indonesia. For each pregnancy, birth outcome and first week survival were traced and recorded from the different registers, as available. Additional local death records were consulted to verify perinatal mortality, or identify deaths not recorded in the health registers. Analyses were performed to assess data quality from registers, and measure perinatal mortality rates. Qualitative research was conducted to explore knowledge and practices of village midwives in register maintenance and reporting of perinatal mortality. RESULTS: Field activities were conducted in 23 villages, covering a total of 1759 deliveries that occurred in 2007. Perinatal mortality outcomes were 23 stillbirths and 15 early neonatal deaths, resulting in a perinatal mortality rate of 21.6 per 1000 live births in 2007. Stillbirth rates for the study population were about four times the rates reported in the routine Maternal and Child Health program information system. Inadequate awareness and supervision, and alternate workload were cited by local midwives as factors resulting in inconsistent data reporting. CONCLUSIONS: Local maternal and child health registers are a useful source of information on perinatal mortality in rural Indonesia. Suitable training, supervision, and quality control, in conjunction with computerisation to strengthen register maintenance can provide routine local area measures of perinatal mortality for health policy, and monitoring of newborn care interventions. Similar efforts are required to strengthen routine health data in all developing countries, to guide planned progress towards reduction in the local, national and international burden from perinatal mortality.